Featured on The Bio Report Podcast - Targeting Senescent Cells
Targeting Senescent Cells to Treat Aging-Related Diseases with Dr. Thomas Ichim
“Aging, at a cellular level, appears to be an infectious process. If we could reduce the number of these aged cells, then we have a shot of obtaining a more profound regenerative activity”
Immorta Bio’s chief scientific officer joins Daniel Levine on The Bio Report podcast to dive into senescent cells and their role in aging-related diseases. Sometimes called “zombie” cells, senescent cells have stopped dividing but do not die as they should. Initially considered harmless, scientific findings have provided evidence that these cells contribute to aging and diseases of aging, including cancer. Thomas also delves into the detailed aspects of Immorta Bio’s innovative cell therapy technologies, highlighting the company's progress in preclinical studies and looking ahead to upcoming clinical trials
Notable Points in the Podcast
3:43 – 6:25 Treating aging as a disease
6:50 – 9:50 Senescent cells and cancer
10:00 – 15:56 Immorta’s approach to cell therapy
16:10 – 19:00 Application of treatment
19:17 – 21:20 Pipeline
21:37 – 26:07 SenoVax™ discussion
26:20 – 32:09 Immorta’s forward missions and goals
Full Podcast:
Follow Immorta Bio